Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions
- May 1st, 2007
- Staff Publication
- Medical Abortion
- Winikoff, Beverly, Aldrich, Tess
This article reports on a study comparing efficacy of four medical abortion regimens used in one clinic setting in a highly restrictive Latin American country. In this real-use setting, methotrexate appears to confer a significant advantage over misoprostol alone for early medical abortion. This finding is important for settings where mifepristone remains unavailable.
Access the abstract.